poisar

Stocks · News reference

Hormel Foods Completes Acquisition of Brakebush Brothers, LLC

Fiscal.ai

Hormel Foods Corporation has finalized its acquisition of Brakebush Brothers, LLC, a move aimed at expanding its portfolio.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — HORMEL FOODS CORP /DE/ (HRL)

    Filed: 2026-11-16 AccNo: 0000048465-26-000065 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

  2. The Motley FoolDave Kovaleski

    This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?

    Hormel Foods, a Dividend King with 60 consecutive years of dividend increases, offers a 5.27% yield—nearly 5 times the S&P 500 average. Despite a 5-year decline of -12.7%, the company shows improving fundamentals with rising free cash flow and a planned $1.1 billion acquisition of Brakebush Brothers to expand into chicken. Wall Street analysts are cautiously optimistic with a median price target of $24.50, suggesting 13% upside potential.

  3. The Motley FoolMicah Zimmerman

    My Forever Portfolio: 5 Dividend-Paying Value Stocks That Are Too Cheap to Ignore

    The article presents five consumer staples dividend-paying stocks trading at discounted valuations: McCormick, Hormel Foods, Kimberly-Clark, Clorox, and Constellation Brands. These companies sell essential products with consistent demand, have long histories of dividend increases, and are currently undervalued despite solid earnings. Recent leadership changes and strategic acquisitions position these stocks as attractive long-term holdings for patient investors.